Futuximab Uses, Dosage, Side Effects and more
Futuximab is under investigation in clinical trial NCT01955473 (Japanese Phase 1 Trial of Sym004 in Solid Tumors).
Trade Name | Futuximab |
Generic | Futuximab |
Futuximab Other Names | Futuximab |
Type | |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | January 7, 2025 at 1:49 am |